ARVN
Arvinas Inc
Price:  
7.54 
USD
Volume:  
2,926,699.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arvinas EV/EBITDA

-292.4%
Upside

As of 2025-06-30, the EV/EBITDA ratio of Arvinas Inc (ARVN) is -5.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Arvinas's latest enterprise value is 469.84 mil USD. Arvinas's TTM EBITDA according to its financial statements is -91.50 mil USD. Dividing these 2 quantities gives us the above Arvinas EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.0x - 12.7x 10.4x
Forward P/E multiples 10.9x - 17.3x 14.4x
Fair Price (12.59) - (14.84) (14.50)
Upside -266.9% - -296.9% -292.4%
7.54 USD
Stock Price
(14.50) USD
Fair Price

Arvinas EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-26 -5.34
2025-06-25 -5.34
2025-06-24 -5.29
2025-06-23 -5.02
2025-06-20 -5.06
2025-06-18 -5.08
2025-06-17 -5.09
2025-06-16 -5.00
2025-06-13 -5.02
2025-06-12 -5.16
2025-06-11 -5.24
2025-06-10 -5.36
2025-06-09 -5.37
2025-06-06 -5.13
2025-06-05 -4.64
2025-06-04 -4.66
2025-06-03 -4.70
2025-06-02 -4.97
2025-05-30 -4.86
2025-05-29 -5.10
2025-05-28 -4.93
2025-05-27 -4.46
2025-05-23 -4.31
2025-05-22 -4.28
2025-05-21 -4.11
2025-05-20 -4.42
2025-05-19 -4.33
2025-05-16 -4.30
2025-05-15 -4.11
2025-05-14 -3.96
2025-05-13 -4.14
2025-05-12 -4.32
2025-05-09 -4.39
2025-05-08 -4.55
2025-05-07 -4.44
2025-05-06 -4.66
2025-05-05 -5.21
2025-05-02 -5.28
2025-05-01 -4.89
2025-04-30 -6.79
2025-04-29 -6.59
2025-04-28 -6.47
2025-04-25 -6.34
2025-04-24 -6.41
2025-04-23 -6.36
2025-04-22 -6.25
2025-04-21 -6.10
2025-04-17 -5.98
2025-04-16 -5.22
2025-04-15 -5.17